Desensitization and drug habituation in HIV-positive subjects.

被引:4
作者
Demoly, P [1 ]
Messaad, D [1 ]
Sahla, H [1 ]
Godard, P [1 ]
Michel, FB [1 ]
Bousquet, J [1 ]
机构
[1] CHU Montpellier, Hop Arnaud de Villeneuve, Clin Malad Resp, F-34295 Montpellier 5, France
来源
REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE | 1998年 / 38卷 / 04期
关键词
desensitization; cotrimoxazole; HIV; drug intolerance; protease inhibitors;
D O I
10.1016/S0335-7457(98)80059-2
中图分类号
R392 [医学免疫学];
学科分类号
100102 [免疫学];
摘要
The frequency of allergic drug reactions is increased in HIV-infected patients and primarily, but not exclusively, concerns sulphonamides. Current data of the literature confirm that cotrimoxazole is the most effective and least expensive form of Pneumocystis carinii pneumonia prophylaxis in HIV-positive patients, but is unfortunately also the least well tolerated drug. Slow and progressive reintroduction (or desensitization) can generally be performed and is effective in most (60 to 95 %) intolerant patients. It is performed over an interval of several hours to several weeks. Similar cases of intolerance to HIV reverse transcriptase inhibitor nucleosides and to HIV-specific protease inhibitors have occasionally been described and have sometimes been successfully treated by desensitization.
引用
收藏
页码:385 / 389
页数:5
相关论文
共 34 条
[1]
DESENSITIZATION TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN HIV-INFECTED PATIENTS [J].
ABSAR, N ;
DANESHVAR, H ;
BEALL, G .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (06) :1001-1005
[2]
BACHMEYER C, 1995, AIDS, V9, P299, DOI 10.1097/00002030-199509030-00013
[3]
Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection [J].
BelchiHernandez, J ;
EspinosaParra, FJ .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1996, 76 (04) :355-358
[4]
BISSUEL F, 1995, AIDS, V9, P407, DOI 10.1097/00002030-199509040-00021
[5]
AIDS-related toxiderma [J].
Bocquet, H ;
Chosidow, O .
REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 1997, 37 (05) :678-684
[6]
Hypersensitivity reactions during antiretroviral regimens with protease inhibitors [J].
Bonfanti, P ;
Capetti, A ;
Riva, P ;
Testa, L ;
Quirino, T .
AIDS, 1997, 11 (10) :1301-1302
[7]
BUHL R, 1989, LANCET, V2, P1294
[8]
CARR A, 1994, CLIN EXP IMMUNOL, V97, P260, DOI 10.1111/j.1365-2249.1994.tb06078.x
[9]
EFFICACY AND SAFETY OF RECHALLENGE WITH LOW-DOSE TRIMETHOPRIM SULFAMETHOXAZOLE IN PREVIOUSLY HYPERSENSITIVE HIV-INFECTED PATIENTS [J].
CARR, A ;
PENNY, R ;
COOPER, DA .
AIDS, 1993, 7 (01) :65-71
[10]
ACETYLATION PHENOTYPE AND CUTANEOUS HYPERSENSITIVITY TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN HIV-INFECTED PATIENTS [J].
CARR, A ;
GROSS, AS ;
HOSKINS, JM ;
PENNY, R ;
COOPER, DA .
AIDS, 1994, 8 (03) :333-337